Emily Phung
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Respiratory viral infections research, Viral gastroenteritis research and epidemiology, Pneumonia and Respiratory Infections, Animal Virus Infections Studies
Most-Cited Works
- → SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness(2020)1,618 cited
- → Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates(2020)1,152 cited
- → A proof of concept for structure-based vaccine design targeting RSV in humans(2019)327 cited
- → Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants(2021)213 cited
- → SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness(2020)142 cited
- → A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone(2020)126 cited
- → COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge(2021)100 cited
- → Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes(2020)73 cited
- → Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses(2021)65 cited
- → Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial(2021)63 cited